Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial
Calabresi, Peter A, Radue, Ernst-Wilhelm, Goodin, Douglas, Jeffery, Douglas, Rammohan, Kottil W, Reder, Anthony T, Vollmer, Timothy, Agius, Mark A, Kappos, Ludwig, Stites, Tracy, Li, Bingbing, CappielVolume:
13
Language:
english
Journal:
The Lancet Neurology
DOI:
10.1016/S1474-4422(14)70049-3
Date:
June, 2014
File:
PDF, 290 KB
english, 2014